The US Food and Drug Administration (FDA) has approved Roche's new drug Gazyva (obinutuzumab) in combination with chlorambucil chemotherapy for treatment of patients with chronic lymphocytic leukemia (CLL) who have not previously been ...
Tags: Combination Vaccine, Medicine
Genentech, a member of the Roche Group, has announced that the US Food and Drug Administration (FDA) has accepted and filed the company's supplemental biologics license application (sBLA) for subcutaneous use of Xolair (omalizumab) in ...
US-based biopharmaceutical firm Tracon Pharmaceuticals has started dosing in a Phase Ib clinical of TRC105 for the treatment of patients with metastatic renal cell carcinoma. The trial evaluates the combination of TRC105 and a standard ...
Tags: Tracon, Carcinoma Drug
Swiss drugmaker F. Hoffmann-La Roche has announced that the EU’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending authorization of Kadcyla as a single agent for the treatment of adult ...
Tags: Breast Cancer Drug
Ventana Medical Systems,a member of the Roche Group, and pharmaceutical company Boehringer Ingelheim (BI) have entered into a collaboration agreement for the development of companion diagnostic tests for BI oncology programs. Companion ...
Shaw Industries Group, Inc. (Shaw) ranked second on Elearning! magazine?'s Learning! 100. Honored for the third consecutive year, Shaw Industries is among the top private sector companies recognized for high performance, organizational ...
Tags: Construction, Decoration
Crate & Barrel is partnering with Italian designer Paola Navone on an exclusive line of home furnishings, with three planned collections set to feature more than 140 items in categories including seating, dining tables, rugs, lighting, ...
Tags: Furniture, Furnishing
India-based Biocon is likely to launch the Swiss drugmaker Roche's Herceptin (trastuzumab) biosimilar version by the end of 31 March 2014, following the latter's decision to give up a patent fight over the breast cancer drug in the country. ...
Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human antibodies against multiple targets. Under the terms ...
Tags: Adimab, Drug Discovery
Australian Pharmaceutical Industries (API) has chosen Tata Consultancy Services to deliver a major IT and business transformation program to integrate and enhance mission-critical IT systems across API’s retail and wholesale ...
India has partly suspended patents granted to Roche Holding for its breast cancer drug Herceptin, over issues that the patents had not been filed in accordance with the laid down process. An article published in Swiss newspaper Schweiz am ...
Tags: Cancer Drug Patent
UNREAL, the unjunked food company, announces that it has launched bold new designs for its unjunked candy packaging and retail displays. Set to roll out in retail stores nationwide, the new designs reflect the essence of the UNREAL brand: ...
Tags: Unjunked Candy, Packaging
Switzerland-based Roche has introduced new Progastrin-releasing peptide (ProGRP) test, Elecsys ProGRP, for precise differentiation of small cell (SCLC) and non-small cell (NSCLC) lung cancer and diagnosis of early-stage SCLC. Used with ...
Tags: Lung Cancer, Peptide Test
Australia's government is to speed up the country's transition to a carbon emissions trading system by dropping its fixed-price carbon tax in 2014, a year earlier than planned, Australian treasurer Chris Bowen said over the weekend. From ...
Oncology-focused drug development company Curis has obtained the conditional approval for Erivedge (vismodegib) to treat adult patients with symptomatic metastatic basal cell carcinoma (BCC) or locally advanced BCC inappropriate for surgery ...